Skip to main content

ALIGN TECHNOLOGY INC

corporate_fare Company Profile

ALIGN TECHNOLOGY INC

ALGN·NASDAQ·Industrial Applications And Services·CIK 0001097149

Align Technology, Inc. is a global medical device company that designs, manufactures, and markets products for orthodontic and restorative dentistry. The company's primary products include Invisalign® clear aligners, used by orthodontists and general dental practitioners (GPs) to treat misaligned teeth. Align also offers Vivera™ retainers for post-treatment retention, iTero™ intraoral scanners and related services for dentistry, and exocad™ computer-aided design and manufacturing (CAD/CAM) software for dental laboratories and practitioners. Align's strategy centers on its Align™ Digital Platform, an integrated suite of technologies and services aimed at providing digital treatment planning and implementation. The company's objectives include establishing Invisalign as a leading solution for malocclusion treatment globally, making iTero intraoral scanners the preferred technology for digital dental scans, and positioning exocad CAD/CAM software as a top choice for dental restorative solutions in labs. The company operates through two segments: Clear Aligner and Imaging Systems and CAD/CAM Services ("Systems and Services"). For the year ended December 31, 2025, the Clear Aligner segment generated approximately 80% of worldwide net revenues, with Systems and Services accounting for the remaining 20%. Align sells most of its products and services directly to customers, including orthodontists, GPs (such as prosthodontists, periodontists, and oral surgeons), and dental laboratories, through a specialized sales force. Align's corporate headquarters are in Tempe, Arizona, with regional headquarters in Raleigh, North Carolina (Americas), Rotkreuz, Switzerland (EMEA), and Singapore (APAC).

ALIGN TECHNOLOGY INC (NASDAQ:ALGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors ALGN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Align Technology Reports Strong Q1 Earnings, Significantly Expands Investment Capacity
  • Align Technology's Q1 Revenue, Profit Beat Estimates; FY Guidance Maintained
  • Align Technology Reports Modest 2025 Revenue Growth Amid Restructuring and Key IP Wins
  • Align Technology Reports Strong Q4 2025 Results Exceeding Expectations, Provides Positive 2026 Outlook

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.03B
Net Income
$410.35M
Diluted EPS
$5.65
Op. Cash Flow
$593.22M
Free Cash Flow
$490.78M
Gross Profit
$2.71B
Operating Income
$545.75M
Cash & Equivalents
$1.09B
Debt / Equity
0.00×
Net Margin
10.2%
Shares Outstanding
71.36M sh
Source: 10-K · filed 2026-02-27 · accession 0001097149-26-000014
Browse all tickers starting with A →
$174.84
52-week range · as of 2026-05-06 $122 – $208.31
Market cap
$12.52B
Volume
574.5K (0.6× avg)
3-mo avg 960.4K
Live data · 2026-06-14 06:08 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ALGN - Latest Insights

ALGN
May 06, 2026, 4:43 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $173.94
Real-time Price: $174.84 info
Change: +$0.900 (+0.52%) info
Market Cap: $12.522B info
ALGN
Apr 29, 2026, 4:18 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $187.60
Real-time Price: $174.84 info
Change: -$12.76 (-7%) info
Market Cap: $12.522B info
ALGN
Feb 27, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $190.10
Real-time Price: $174.84 info
Change: -$15.26 (-8%) info
Market Cap: $12.522B info
ALGN
Feb 04, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $167.32
Real-time Price: $174.84 info
Change: +$7.52 (+4%) info
Market Cap: $12.522B info